A former FDA official underscored dysfunction within the FDA that he believes exacerbated last year's nationwide infant formula shortage.
The baby formula industry is still vulnerable to safety issues and supply disruptions more than a year after a nationwide shortage, a former Food and Drug Administration official told U.S. lawmakers.
Frank Yiannas, former deputy commissioner of the office of food policy and response at the Food and Drug Administration , speaks during a House Oversight and Accountability Subcommittee hearing in Washington, DC, on Tuesday, March 28, 2023.The U.S. supply of infant formula industry is still vulnerable to safety issues and supply disruptions more than a year after a nationwide shortage that left parents scrambling to feed their children, a former Food and Drug Administration official told U.S.
He said the agency was slow to act when those concerns about contamination arose at Abbott's formula manufacturing plant in Sturgis, Mich. The plant was shuttered for months, sharply reducing formula supply across the U.S. Prior to the recall, Abbott controlled anYiannas underscored dysfunction within the FDA that he believes exacerbated the shortage.
He instead pointed to decentralized offices and centers at the agency that were slow to pass along the critical information, he noted.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA knew about latest baby formula problem months before recallFDA inspectors knew about contamination at the Enfamil plant in November, three months before the recall.
Read more »
FDA Approves New Formulation of Hyrimoz Adalimumab BiosimilarThe agency approved a higher concentration formulation of Hyrimoz for its previous indications, including rheumatoid arthritis and psoriasis.
Read more »
FDA stonewalled abortion drug concerns to escape responsibility for their dangers[This is part three of a series on the first-of-its-kind federal lawsuit, Americans for Hippocratic Medicine v. U.S. Food and Drug Administration, in which doctors and medical practitioners are asking the courts to hold the FDA accountable for its reckless and illegal approval of dangerous chemical…
Read more »
FDA Approves Pharming's Immune Disorder DrugThe US Food and Drug Administration on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened immune system, the Dutch company said.
Read more »
‘Lessons have not been learned’: FDA knew of positive test months before latest infant formula recallIn late February, formula giant Reckitt issued a press release recalling 145,000 cans of Enfamil ProSobee Simply Plant-Based Infant Formula over the “possibility of cross-contamination with Cronobacter sakazakii”
Read more »
FDA proposes overhaul of fast-track process for cancer medsThe Food and Drug Administration is eyeing policy changes that could make drugmakers conduct more stringent trials to win fast-track approvals of cancer drugs.
Read more »